ArticlePharmacogenetics and genomics2016

Pharmacogenetics of efavirenz discontinuation for reported central nervous system symptoms appears to differ by race.

Paul Leger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.